Results 51 to 60 of about 238,637 (182)

MITF maintains genome stability in nonmelanocyte lineages

open access: yesMolecular Oncology, EarlyView.
MITF is essential for melanocyte survival and acts as an oncogene in 10%–20% of melanomas. We show that MITF depletion causes genome instability in nonmelanocytic cells, leading to LATS2‐mediated P53 activation, cell cycle arrest, and apoptosis. This study highlights the role of MITF as a genome maintenance factor beyond the melanocyte lineage. Created
Drifa H. Gudmundsdottir   +13 more
wiley   +1 more source

Evaluation of the inner thigh as site for mantoux test among children in Owerri South EasternNigeria

open access: yesNigerian Journal of Paediatrics, 2016
Background: Mantoux test, a type IV hypersensitivity reaction, is commonly used to screen children for possible tuberculosis. It is applied on the volar surface of forearm.
Ezeogu J   +3 more
doaj  

Oncogenic DMTF1β promotes cancer cell motility by regulating autophagy through ULK1 stabilization

open access: yesMolecular Oncology, EarlyView.
In the current study, we demonstrate that the oncogene DMTF1β regulates ULK1 stability by reducing its proteasomal degradation in cancer cells. This stabilization enables ULK1 to induce autophagy, which in turn facilitates cancer cell migration. Consequently, reduced DMTF1β levels lead to decreased autophagy and impaired cancer cell migration.
Jun Xu   +13 more
wiley   +1 more source

TB Stigma Theory and Measurement

open access: yes, 2018
There is a science to stigma measurement that brings TB stigma into focus. This book will orient the reader to the basics of TB stigma measurement. Mapping stigma becomes feasible once its underlying mechanisms are understood. The means by which bias and
Craig, Gillian
core   +4 more sources

Prevalence of Multidrug-Resistant TB Among Smear-Positive Pulmonary TB Patients in Banadir, Somalia: A Multicenter Study

open access: yesInfection and Drug Resistance, 2022
Abdirahman Mohamed Hassan Dirie,1 Sedat Çolakoğlu,1 Osman Muhyadin Abdulle,2 Bashir Mohamud Abdi,3 Mohamed Abdi Osman,4 Abdiaziz Mohamud Shire,5 Abdinafic Mohamud Hussein6 1Pulmonology Department, Somalia Mogadishu Turkey Recep Tayyip Erdogan ...
Dirie AMH   +6 more
doaj  

Inhibition of cyclin‐dependent kinases 12/13 using CT7439 as a treatment for colorectal cancer with CDK12 upregulation

open access: yesMolecular Oncology, EarlyView.
The proposed mechanism of action for the CDK12/13 inhibitor and cyclin K degrader, CT7439. CDK12/13 inhibition interrupts transcription elongation, leading to increased DNA damage that results in cell death. This agent is a potentially novel treatment option for patients with colorectal cancer. Created in BioRender. Cyclin‐dependent kinase (CDK) 12 and
Wylie K. Watlington   +10 more
wiley   +1 more source

Pharmacological chromatin remodeling enhances response to estrogen therapy in ER+ breast cancer

open access: yesMolecular Oncology, EarlyView.
Estrogen therapy elicits clinical benefit in ~ 30% of patients with endocrine‐resistant estrogen receptor (ER)‐positive breast cancer. Based on findings that ER transcriptional activation underlies response to estrogen therapy, we tested the effects of epigenetic dysregulation via pharmacological inhibition of histone deacetylases (HDACi).
Anneka L. Johnson Thomas   +16 more
wiley   +1 more source

PANoptosis in the pathogenesis of myelodysplastic syndromes

open access: yesMolecular Oncology, EarlyView.
PANoptosis, a combination of three types of programmed cell death, is mediated by a large protein complex called a PANoptosome. In healthy bone marrow hematopoietic cells, PANoptosis is restricted by inhibitory signaling. In MDS, bone marrow cells become sensitive to the PANoptotic stimuli due to the aberrant inactivation of inhibitory signaling or ...
Rohit Thalla   +4 more
wiley   +1 more source

Protocol for a phase 2, partially blinded, randomized trial assessing the safety and efficacy of sorfequiline or bedaquiline in combination with pretomanid and linezolid in adult participants with newly diagnosed, drug-sensitive, smear-positive pulmonary tuberculosis (NC-009)

open access: yesTrials
Introduction In 2023, tuberculosis (TB) returned to being the world’s leading cause of death from a single infectious agent. Current standard of care for drug-sensitive tuberculosis (DS-TB) treatment has a long duration with risk of poor compliance and ...
M. Olugbosi   +16 more
doaj   +1 more source

Tuberculosis in Migrants is Among the Challenges of Tuberculosis Control in High-Income Countries

open access: yesRisk Management and Healthcare Policy, 2021
Endrias Markos Woldesemayat School of Public Health, College of Medicine and Health Sciences, Hawassa University, Hawassa, EthiopiaCorrespondence: Endrias Markos Woldesemayat Email endromark@yahoo.comAbstract: The incidence of tuberculosis (TB) is high ...
Woldesemayat EM
doaj  

Home - About - Disclaimer - Privacy